Deutsche Bank’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
180,889
+53,074
+42% +$955K ﹤0.01% 1887
2025
Q4
$3.47M Buy
127,815
+101,078
+378% +$2.52M ﹤0.01% 1494
2025
Q3
$503K Buy
26,737
+3,334
+14% +$51.8K ﹤0.01% 2536
2025
Q2
$257K Buy
23,403
+8,211
+54% +$75.8K ﹤0.01% 2826
2025
Q1
$93K Buy
15,192
+341
+2% +$3.26K ﹤0.01% 3222
2024
Q4
$244K Buy
+14,851
New +$332K ﹤0.01% 3008

Other funds holding UPB

Deutsche Bank's UPB Position: Q1 2026 in Review

Deutsche Bank increased its Upstream Bio Inc (UPB) stake by 42% in Q1 2026, buying an estimated $955K and bringing the position to 180,889 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

Deutsche Bank first reported a position in UPB in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.47M in Q4 2025. 140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Deutsche Bank held 180,889 shares of Upstream Bio Inc worth $1.63M as of Q1 2026.
  • Deutsche Bank bought 53,074 Upstream Bio Inc shares in Q1 2026, an estimated $955K.
  • Upstream Bio Inc made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1887 holding.
  • Deutsche Bank first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 6 quarters since.
  • Deutsche Bank's Upstream Bio Inc position peaked at $3.47M in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.